Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover various wealth accumulation methods and strategies to enhance your financial growth. Start implementing them now.
28,655 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A fintech startup faced backlash after an autonomous AI claimed a non-existent policy, underscoring how deployment ch...
Figure Technology Solutions delivered a powerful first quarter, as blockchain lending activity surged and revenue nea...
A pre-retiree left for a rival firm and forfeited $74,000 in 401(K) employer matching by missing the vesting cliff. T...
Speculative AI-driven forecasts tied to Sam Altman's tools predict altman chatgpt predicts incredible upside for DOGE...
The latest BEA data show the Fed's preferred inflation measure at a three-year high, signaling price pressures may pe...
A 60-year-old who converted $400,000 to a Roth IRA in 2025 plans a $50,000 withdrawal in 2026, only to confront two s...
The Tortoise AI Infrastructure ETF (TCAI) is drawing attention as data-center power, cooling, and fiber networks surg...
New data show housing demand growth reflects a split in local markets, where some areas see price adjustments and lar...
A veteran tech executive leaves Dell to build a startup that reframes how large companies buy AI, insisting too many ...
A Korea-led chip selloff pulled AMD and Intel lower while Nvidia slipped, prompting analysts to frame the move as hea...
A fresh market screen identifies five high-yield dividend stocks trading under $10, presenting a potential income lif...